# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-18-015138
Filing Date
2018-11-08
Accepted
2018-11-08 13:39:43
Documents
15
Period of Report
2018-11-08

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | REPORT OF FOREIGN PRIVATE ISSUER | f6k110818_xtlbiopharma.htm | 6-K | 11282
2 | XTL BIOPHARMACEUTICALS LTD. INVESTOR PRESENTATION | f6k110818ex99-1_xtlbio.htm | EX-99.1 | 16167
3 | GRAPHIC | ex99-1_001.jpg | GRAPHIC | 249572
4 | GRAPHIC | ex99-1_002.jpg | GRAPHIC | 458180
5 | GRAPHIC | ex99-1_003.jpg | GRAPHIC | 202523
6 | GRAPHIC | ex99-1_004.jpg | GRAPHIC | 316673
7 | GRAPHIC | ex99-1_005.jpg | GRAPHIC | 217266
8 | GRAPHIC | ex99-1_006.jpg | GRAPHIC | 223549
9 | GRAPHIC | ex99-1_007.jpg | GRAPHIC | 245801
10 | GRAPHIC | ex99-1_008.jpg | GRAPHIC | 230605
11 | GRAPHIC | ex99-1_009.jpg | GRAPHIC | 227451
12 | GRAPHIC | ex99-1_010.jpg | GRAPHIC | 252637
13 | GRAPHIC | ex99-1_011.jpg | GRAPHIC | 349449
14 | GRAPHIC | ex99-1_012.jpg | GRAPHIC | 202596
15 | GRAPHIC | ex99-1_013.jpg | GRAPHIC | 172863
| Complete submission text file | 0001213900-18-015138.txt |  | 4642575

Mailing Address 5 HACHAROSHET ST. RAANANA L3 4365603
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-36000 | Film No.: 181169152
SIC: 2834 Pharmaceutical Preparations